Merck's HPV vaccine gets China approval for men amid declining sales - Reuters.com

Merck's HPV vaccine gets China approval for men amid declining sales  Reuters.com

Merck Snaps Up WuXi Biologics Facility in Ireland for $500M - BioSpace

Merck Snaps Up WuXi Biologics Facility in Ireland for $500M  BioSpace

In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics - FiercePharma

In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics  FiercePharma

Merck KGaA (ETR:MRK) Shares Down 1.4% - What's Next? - MarketBeat

Merck KGaA (ETR:MRK) Shares Down 1.4% - What's Next?  MarketBeat

Merck Gets China Nod on HPV Shot for Men Amid Sales Slump - Bloomberg

Merck Gets China Nod on HPV Shot for Men Amid Sales Slump  Bloomberg

Merck KGaA Adopts Bio-AI Clinical Prediction Platform - Contract Pharma

Merck KGaA Adopts Bio-AI Clinical Prediction Platform  Contract Pharma

Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic ...

Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer  GlobeNewswire

Merck is a new year outlier with its diabetes drug - STAT

Merck is a new year outlier with its diabetes drug  STAT

Astra, Merck Drugs Set to Shake Up Liver Cancer Treatment | Company Business News - Mint

Astra, Merck Drugs Set to Shake Up Liver Cancer Treatment | Company Business News  Mint

Merck Announces FDA Acceptance of Biologics License Application for Clesrovimab, an Investigation...

Merck Announces FDA Acceptance of Biologics License Application for Clesrovimab, an Investigational Long-Acting Monoclonal Antibody Designed to Protect Infants from RSV Disease During their First RSV Season  Business Wire

China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom - Reuters.com

China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom  Reuters.com

Merck to buy WuXi Biologics' Irish vaccine facility for $500 million - Yahoo Finance

Merck to buy WuXi Biologics' Irish vaccine facility for $500 million  Yahoo Finance

Gordon Reid's Top Picks: Goldman Sachs, PulteGroup and Merck - BNN Bloomberg

Gordon Reid's Top Picks: Goldman Sachs, PulteGroup and Merck  BNN Bloomberg

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative ...

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants  Merck

Merck Signs MoU with Gene Therapy Research Institution - Merck KGaA

Merck Signs MoU with Gene Therapy Research Institution  Merck KGaA

Merck KGaA effectively manages import and invoice risk in China - JP Morgan

Merck KGaA effectively manages import and invoice risk in China  JP Morgan

Quris-AI's Bio-AI Platform Integrated by Merck KGaA, - GlobeNewswire

Quris-AI's Bio-AI Platform Integrated by Merck KGaA,  GlobeNewswire

Pimicotinib Topline Results | Merck - Merck KGaA

Pimicotinib Topline Results | Merck  Merck KGaA

Merck wins UK approval for lung disease drug acquired in $11 billion deal - Reuters

Merck wins UK approval for lung disease drug acquired in $11 billion deal  Reuters

Modifi Biosciences Acquired by Merck - GlobeNewswire

Modifi Biosciences Acquired by Merck  GlobeNewswire

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal - CNBC

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal  CNBC

Merck Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA - Merck KGaA

Merck Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA  Merck KGaA

N.C. A&T, Merck Introduce High School Students to Biotechnology - North Carolina A&T

N.C. A&T, Merck Introduce High School Students to Biotechnology  North Carolina A&T

Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy - BioPharma Dive

Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy  BioPharma Dive

Merck and Siemens enter Strategic Partnership on Digital Transformation Technology - Merck KGaA

Merck and Siemens enter Strategic Partnership on Digital Transformation Technology  Merck KGaA

Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal - BioSpace

Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal  BioSpace

Merck Completes Acquisition of Unity-SC and Strengthens Optronics Offering - Merck KGaA

Merck Completes Acquisition of Unity-SC and Strengthens Optronics Offering  Merck KGaA

Merck, A&T launch joint Merck Biotechnology Learning Center - North Carolina A&T

Merck, A&T launch joint Merck Biotechnology Learning Center  North Carolina A&T

FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pu...

FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)  Merck

Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer - Business Wire

Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer  Business Wire

How we’re addressing health literacy - Merck

How we’re addressing health literacy  Merck

Merck Launches M-Trace® | Merck - Merck KGaA

Merck Launches M-Trace® | Merck  Merck KGaA

Merck Signs Agreement to Sell Surface Solutions Business Unit to GNMI - Merck KGaA

Merck Signs Agreement to Sell Surface Solutions Business Unit to GNMI  Merck KGaA

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova - Reuters

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova  Reuters

Merck KGaA’s AI Platform Architect On Redefining The Drug Discovery Process - News & Insights

Merck KGaA’s AI Platform Architect On Redefining The Drug Discovery Process  News & Insights

Capital Markets Day 2024: Merck Reiterates Confidence in Returning to Sustainable Growth - Merck ...

Capital Markets Day 2024: Merck Reiterates Confidence in Returning to Sustainable Growth  Merck KGaA

Merck sees Gardasil China woes carrying into 2025 - Reuters

Merck sees Gardasil China woes carrying into 2025  Reuters

Merck publishes 2023/2024 Impact Report - Merck

Merck publishes 2023/2024 Impact Report  Merck

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln - Reuters

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln  Reuters

Merck lays off workers amid rough pharma job market - STAT

Merck lays off workers amid rough pharma job market  STAT

Merck to Discontinue KEYNOTE-867 and KEYNOTE-630 Trials of Pembrolizumab in NSCLC, CSCC - OncLive

Merck to Discontinue KEYNOTE-867 and KEYNOTE-630 Trials of Pembrolizumab in NSCLC, CSCC  OncLive

Hammond receives Merck research fellowship - WashU Medicine

Hammond receives Merck research fellowship  WashU Medicine

Patient support programs - Merck

Patient support programs  Merck

How Merck Automated AWS Elastic Disaster Recovery Initialization and Monitoring - AWS Blog

How Merck Automated AWS Elastic Disaster Recovery Initialization and Monitoring  AWS Blog

A new foundation for future talent - Merck

A new foundation for future talent  Merck

Our Q3 2024 financial results - Merck

Our Q3 2024 financial results  Merck

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering - Merck KGaA

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering  Merck KGaA

Why Did Merck Stock Rise 65%? - Forbes

Why Did Merck Stock Rise 65%?  Forbes

Merck sets sights on brain cancer with $30M Modifi acquisition - Fierce Biotech

Merck sets sights on brain cancer with $30M Modifi acquisition  Fierce Biotech

Germany's Merck sells pigments unit to China's GNMI for $721 mln - Reuters.com

Germany's Merck sells pigments unit to China's GNMI for $721 mln  Reuters.com

Merck KGaA Fails Phase III Study in Head and Neck Cancer, Scraps Trials - BioSpace

Merck KGaA Fails Phase III Study in Head and Neck Cancer, Scraps Trials  BioSpace

News 26 July 2024 | Merck - Merck KGaA

News 26 July 2024 | Merck  Merck KGaA

Merck stops testing combo drug for lung cancer - Reuters.com

Merck stops testing combo drug for lung cancer  Reuters.com

Merck, Daiichi Score Late-Stage NSCLC Win for ADC, Flag Two Deaths - BioSpace

Merck, Daiichi Score Late-Stage NSCLC Win for ADC, Flag Two Deaths  BioSpace

Business development and licensing (BD&L) - Merck

Business development and licensing (BD&L)  Merck

Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data - Fierce Biotech

Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data  Fierce Biotech

Merck raises outlook for electronics and healthcare, sees improved chip market demand - Reuters

Merck raises outlook for electronics and healthcare, sees improved chip market demand  Reuters

Merck Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing - Merck KGaA

Merck Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing  Merck KGaA

Merck & Co. signs $1.9B deal with Mestag to explore fibroblast therapies for inflammation - Fierc...

Merck & Co. signs $1.9B deal with Mestag to explore fibroblast therapies for inflammation  Fierce Biotech

Merck Animal Health Veterinary Team study reveals factors associated with well-being, burnout, an...

Merck Animal Health Veterinary Team study reveals factors associated with well-being, burnout, and mental health among nonveterinarian practice team members  American Veterinary Medical Association

Our Q2 2024 sales and earnings report - Merck

Our Q2 2024 sales and earnings report  Merck

Merck Biotech Development Center, Corsier-sur-Vevey, Switzerland - Pharmaceutical Technology

Merck Biotech Development Center, Corsier-sur-Vevey, Switzerland  Pharmaceutical Technology

Daiichi Pays Merck $170M for T-Cell Engager, Expands ADC Partnership - BioSpace

Daiichi Pays Merck $170M for T-Cell Engager, Expands ADC Partnership  BioSpace

White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600...

White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600 million  White & Case LLP

Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial...

Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial  STAT

Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership? - BioSpace

Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?  BioSpace

Merck to Acquire EyeBio - Business Wire

Merck to Acquire EyeBio  Business Wire

Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy - BioSpace

Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy  BioSpace

Merck mystified by sudden 'step down' in Gardasil sales in China - FiercePharma

Merck mystified by sudden 'step down' in Gardasil sales in China  FiercePharma

Merck Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing - Merck...

Merck Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing  Merck KGaA

Merck Joins German Research Project "Semiconductor-X" - Merck KGaA

Merck Joins German Research Project "Semiconductor-X"  Merck KGaA

Is Merck Stock A Better Pick Over AbbVie? - Forbes

Is Merck Stock A Better Pick Over AbbVie?  Forbes

Lauren Gardner wins Merck prize to advance pandemic tracking with artificial intelligence - The H...

Lauren Gardner wins Merck prize to advance pandemic tracking with artificial intelligence  The Hub at Johns Hopkins

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival - FiercePh...

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival  FiercePharma

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecif...

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.  Yahoo Finance

Concern over Merck's Gardasil sales in China sink shares - Reuters.com

Concern over Merck's Gardasil sales in China sink shares  Reuters.com

Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now - Yahoo Finance

Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now  Yahoo Finance

Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems: Reuters - ...

Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems: Reuters  BioSpace

Merck pursuing next-generation breaks in cardiometabolic drugs - Reuters.com

Merck pursuing next-generation breaks in cardiometabolic drugs  Reuters.com

Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific comb...

Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific combo  Fierce Biotech

US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug - Reuters.com

US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug  Reuters.com

Merck KGaA shares plunge after cancer drug hopeful fails - Reuters.com

Merck KGaA shares plunge after cancer drug hopeful fails  Reuters.com

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30 - Business Wire

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30  Business Wire

Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner - Merck KGaA

Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner  Merck KGaA

Prostate cancer: stigma, early screening and support - Merck

Prostate cancer: stigma, early screening and support  Merck

Chemistry Postdoc Francisco Martins Honored by Merck with National Award - University of Houston

Chemistry Postdoc Francisco Martins Honored by Merck with National Award  University of Houston

Neuroscience - Merck

Neuroscience  Merck

Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cance...

Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer  Fierce Biotech

Merck KGaA's CDMO unit continues to slide but company sees an uptick coming - FiercePharma

Merck KGaA's CDMO unit continues to slide but company sees an uptick coming  FiercePharma

Should You Pick Merck Stock At $115 After A Q2 Beat? - Forbes

Should You Pick Merck Stock At $115 After A Q2 Beat?  Forbes

Eli Merck - 2024 - Football - University of Oklahoma - Soonersports.com

Eli Merck - 2024 - Football - University of Oklahoma  Soonersports.com

Work Areas - Merck KGaA

Work Areas  Merck KGaA

Merck defeats appeal by nearly 1,200 shingles vaccine plaintiffs - Reuters.com

Merck defeats appeal by nearly 1,200 shingles vaccine plaintiffs  Reuters.com

Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts - Yahoo F...

Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts  Yahoo Finance

Merck: Innovation powered by digital and data - Nature.com

Merck: Innovation powered by digital and data  Nature.com

Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany - Merck KGaA

Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany  Merck KGaA

Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million - ...

Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million  Merck KGaA

Compliance-Hotline - Merck KGaA

Compliance-Hotline  Merck KGaA

M Lab™ Shanghai 2024 | Merck - Merck KGaA

M Lab™ Shanghai 2024 | Merck  Merck KGaA